Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis
about
Immune and inflammatory mechanisms in pulmonary arterial hypertensionHeterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.Diagnosis and management of pulmonary hypertension in systemic sclerosis.HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosisScleroderma lung diseaseSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesDetection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.Lung involvement in systemic sclerosis.Pulmonary arterial hypertension associated with systemic sclerosis.Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations.Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and IIIPulmonary arterial hypertension in connective tissue diseases.Antinuclear antibodies.Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular diseaseUnique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune responseAntifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes.A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.Isolated pulmonary veno-occlusive disease and pulmonary arterial thrombosis in systemic sclerosis - a lethal combination.Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.Nitric Oxide positively regulates Ag (I)-induced Ca(2+) influx and mast cell activation: role of a Nitric Oxide Synthase-independent pathway.Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.Molecular structure and function of autoantigens in systemic sclerosis.Autoantibodies in systemic sclerosis.Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: a case reportCa2+-dependent mast cell death induced by Ag (I) via cardiolipin oxidation and ATP depletion.Muscle involvement in systemic sclerosis: points to consider in clinical trials.Immune cells and autoantibodies in pulmonary arterial hypertension.Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
P2860
Q26851508-E6168496-DB90-4D77-B6C8-A7B807530899Q33293736-B46CE4E1-7935-4753-A1EB-49E2040E2B85Q33649923-2F56B136-5F33-490F-AD63-BC432CA7C5F8Q33832379-04F54FC9-1F5D-464F-98BE-CC825D22E299Q33855367-6612E2A5-5701-4554-8B59-2343E4035E48Q33895346-79A236CE-216B-4A91-A033-58A991A8182AQ33919119-D6F27B25-954C-4B95-B18D-078645AE4B1FQ33965825-1B0768C7-6707-41A8-BF1A-54515F2CB8FEQ34045145-D1A87C1E-EC88-41AB-9075-273D0812350DQ34732817-8599788E-C34D-40C9-8896-22558C5DE8A0Q35002423-3D8AC423-CC5E-47BF-8F6D-E213524F26DCQ35009486-F0BE9238-A129-4D0B-B350-4F00A15DCD87Q35146164-7C551E81-F43C-4162-84FD-33782DAE49C5Q35549272-AF7CAD3D-B1AB-4903-A9B8-56CA430198FCQ35557818-EDE0EEB4-FF0C-4752-870D-85841C3190C6Q35611011-BABDB16E-5100-4CE2-BD14-6EA59BA839C9Q36075852-767B6679-5C59-4DAB-B2FC-692A9D76F34AQ36086118-EE9C63B0-CF19-40DA-B4B6-87296442F90AQ36130814-0081AADA-C91B-4285-AB24-8BD0841D53F2Q36350110-4F980DEB-F18B-41AA-880E-97C4B063A98BQ36364496-84724952-9CAA-46F8-BBFF-B41DB57D542BQ36570354-EF7E2C49-A351-4863-B7FC-D55C909C9C08Q36592069-CAFECCBF-D52A-407B-AD8D-3007B8C215F4Q36774814-EDB3FB24-05AC-4DB6-8BD5-23E929129CA0Q36856521-6130D566-F6A5-40DE-80DD-5CBCB1B36B5BQ37336586-3138EABD-7D57-410D-9676-256BB6CF39EDQ37955130-B3203869-5C22-43F1-B032-9C934D5CCC2AQ38075430-245534FE-F0DC-4EC1-859D-BF86685C815CQ38111730-E3D832D6-BA11-43FC-BF2F-2F4CC0BD630CQ38730172-51B4AD6D-D6A3-41B3-8D05-D56169126A72Q38862644-41F2BA99-331C-4AE2-91ED-977A815B031FQ39808196-7E8D9886-2B1E-4CDF-9453-413BD598C33AQ40087587-1DD1AC1E-A82D-4614-8EF3-58704818F29DQ40468515-6A26BA84-7CD5-4699-9AB1-CCD87F0A05DEQ40468520-DA869D9F-FE04-4ADD-89CA-8B64DF39061AQ41887990-9AF53081-045C-4DC9-82F0-D9D78365F86DQ46032989-3DAC0DCB-C280-4EAF-90E2-4C9FED317879Q46256178-620E17AB-620C-4D7E-A69C-C36894A0BFF0Q47742357-1A3F2A06-B841-4E14-BCA6-A6D20C1104AAQ49486890-C5A0CBCF-1EE6-4F3E-98F1-1BBA17F415D2
P2860
Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@ast
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@en
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@nl
type
label
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@ast
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@en
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@nl
prefLabel
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@ast
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@en
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@nl
P2093
P3181
P356
P1476
Autoantibody to U3 nucleolar r ...... tients with systemic sclerosis
@en
P2093
P2860
P304
P3181
P356
10.1002/ART.1780350114
P407
P577
1992-01-01T00:00:00Z